Aeras infectious news

Aeras, a not-for-profit biotech developing TB vaccines, received a grant of up to $220 million over five years from the Bill & Melinda Gates Foundation. Aeras said the funding is based on preclinical and clinical development milestones. Aeras has six TB vaccines in clinical development. The two most advanced are MVA85A and AERAS-402/Crucell Ad35, both of which are in Phase IIb testing. ...